PUBLIC COMPANYResearches and sells prescription medicines, vaccines and animal health products.
Merck sells pharmaceuticals and vaccines to wholesalers, health systems and governments, and it also has an animal health business. Cancer, infectious disease and cardiovascular products are major areas. The stock is listed on the NYSE, and its annual report gives a full description of the business, its risks and its audited financial statements. The filings explain product concentration and patent timelines, both of which are useful to review.
Merck is a large pharmaceutical company based in Rahway, New Jersey. It makes medicines and vaccines for cancer, infections and other conditions. Its cancer immunotherapy drug Keytruda is one of the best selling medicines in the world.
Merck earns from selling prescription drugs and vaccines to hospitals, doctors and pharmacies, protected by patents. A single top product can make up a large share of sales, which is a strength while the patent lasts and a challenge afterward.
The company must find new products to replace those losing patent protection. Drug pricing rules, clinical trial results and competition shape the picture. Investors often study the pipeline to judge what comes next.
What is immunotherapy?
A treatment that helps the body’s immune system fight disease such as cancer.
Why is patent expiry a big deal?
Cheaper generic versions can take sales away.
Does Merck sell vaccines?
Yes, along with its other medicines.
Open the latest annual report, called a 10-K, and look at the share of sales from its top products, patent dates and the pipeline. Reading the company in its own words is the best way to see how it really works.
This page is for education only. It is not advice to buy or sell anything.
Official reports for Merck & Co., Inc. are on the SEC site. Open the filings for MRK. Public company facts here come from official filings and the company itself.
Claim this profile to correct facts, add your website and news, and keep it current. Basic claiming is free. Paid features, like press releases and spotlights, are always labeled.
Claim this profile See company spotlightsProfile written by Positive Stocks from public information, last checked in October 2026. Details change, so confirm with the company and its filings. This is for education only. It is not a recommendation to buy or sell anything. Investing involves risk, including loss of money.